Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

by Bamias, A., Cunningham, D., Nicolson, V., Norman, A., Hill, M., Nicolson, M., O'Brien, M., Webb, A., Hill, A.
Published 1995

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.

by Hird, V., Verhoeyen, M., Badley, R. A., Price, D., Snook, D., Kosmas, C., Gooden, C., Bamias, A., Meares, C., Lavender, J. P.
Published 1991

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

by Bamias, A, Tzannis, K, Beuselinck, B, Oudard, S, Escudier, B, Diosynopoulos, D, Papazisis, K, Lang, H, Wolter, P, de Guillebon, E, Stravodimos, K, Chrisofos, M, Fountzilas, G, Elaidi, R-T, Dimopoulos, M A, Bamia, C
Published 2013

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

by Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Published 2012

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC

by Ko, J J, Choueiri, T K, Rini, B I, Lee, J-L, Kroeger, N, Srinivas, S, Harshman, L C, Knox, J J, Bjarnason, G A, MacKenzie, M J, Wood, L, Vaishampayan, U N, Agarwal, N, Pal, S K, Tan, M-H, Rha, S Y, Yuasa, T, Donskov, F, Bamias, A, Heng, D Y C
Published 2014